Roy Levitt | Clinical Professor, Director, UHealth Institute for Advanced Pain Management Center
UNIVERSITY OF MIAMI

Roy Levitt is a Clinical Professor, Vice Chairmant of the Department of Anesthesiology, and Director at the UHealth Institute for Advanced Pain Management at the University of Miami. He specializes in interventional pain management and has a strong focus on advancing novel therapeutic approaches for chronic pain. Dr. Levitt has extensive experience in both clinical care, research, and therapeutics development, with a particular emphasis on translating emerging science into practical treatment strategies. His work includes evaluating innovative modalities such as gene-based therapies aimed at addressing the underlying mechanisms of pain with novel neuromodulators, rather than solely managing symptoms. Throughout his career in prominent academic institutions and pharaceutical industry, Dr. Levitt has been committed to improving outcomes for patients with chronic and refractory pain conditions through evidence-based, personalized care. He is actively engaged in clinical research and collaborates with multidisciplinary teams to bring next-generation therapies into clinical settings. At Advanced Therapies USA 2026, Dr. Levitt will present on the clinical potential of replication-defective HSV (rdHSV) gene therapies for chronic pain management. His talk will focus on mechanism of action, translational considerations, and the evolving role of gene therapy in treating various forms of chronic pain, offering attendees a practical, clinically grounded perspective on this emerging field.